Tanshinol attenuates oxidative stress through the down-regulation of FoxO3a signaling, and at least partially reverses the decrease in osteoblastic differentiation, making it a possible drug in the therapy of osteoporosis.30 The gene discussed is FOXO3; the disease is osteoporosis.